335 related articles for article (PubMed ID: 24811133)
1. Effects of GLP-1 on appetite and weight.
Shah M; Vella A
Rev Endocr Metab Disord; 2014 Sep; 15(3):181-7. PubMed ID: 24811133
[TBL] [Abstract][Full Text] [Related]
2. Interactions between gastric emptying and satiety, with special reference to glucagon-like peptide-1.
Hellström PM; Näslund E
Physiol Behav; 2001; 74(4-5):735-41. PubMed ID: 11790437
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide 1 and appetite.
Dailey MJ; Moran TH
Trends Endocrinol Metab; 2013 Feb; 24(2):85-91. PubMed ID: 23332584
[TBL] [Abstract][Full Text] [Related]
4. Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala.
Parker JA; McCullough KA; Field BC; Minnion JS; Martin NM; Ghatei MA; Bloom SR
Int J Obes (Lond); 2013 Oct; 37(10):1391-8. PubMed ID: 23337772
[TBL] [Abstract][Full Text] [Related]
5. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
[TBL] [Abstract][Full Text] [Related]
6. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.
Chelikani PK; Haver AC; Reidelberger RD
Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1695-706. PubMed ID: 15718384
[TBL] [Abstract][Full Text] [Related]
7. New physiological effects of the incretin hormones GLP-1 and GIP.
Asmar M
Dan Med Bull; 2011 Feb; 58(2):B4248. PubMed ID: 21299928
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide containing pathways in the regulation of feeding behaviour.
Tang-Christensen M; Vrang N; Larsen PJ
Int J Obes Relat Metab Disord; 2001 Dec; 25 Suppl 5():S42-7. PubMed ID: 11840214
[TBL] [Abstract][Full Text] [Related]
9. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity.
Flint A; Raben A; Ersbøll AK; Holst JJ; Astrup A
Int J Obes Relat Metab Disord; 2001 Jun; 25(6):781-92. PubMed ID: 11439290
[TBL] [Abstract][Full Text] [Related]
10. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner.
Hata T; Mera Y; Ishii Y; Tadaki H; Tomimoto D; Kuroki Y; Kawai T; Ohta T; Kakutani M
J Pharmacol Exp Ther; 2011 Mar; 336(3):850-6. PubMed ID: 21139060
[TBL] [Abstract][Full Text] [Related]
11. Regulation of gastric emptying rate and its role in nutrient-induced GLP-1 secretion in rats after vertical sleeve gastrectomy.
Chambers AP; Smith EP; Begg DP; Grayson BE; Sisley S; Greer T; Sorrell J; Lemmen L; LaSance K; Woods SC; Seeley RJ; D'Alessio DA; Sandoval DA
Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E424-32. PubMed ID: 24368666
[TBL] [Abstract][Full Text] [Related]
12. Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure.
Bagger JI; Holst JJ; Hartmann B; Andersen B; Knop FK; Vilsbøll T
J Clin Endocrinol Metab; 2015 Dec; 100(12):4541-52. PubMed ID: 26445112
[TBL] [Abstract][Full Text] [Related]
13. An inter-organ neural circuit for appetite suppression.
Zhang T; Perkins MH; Chang H; Han W; de Araujo IE
Cell; 2022 Jul; 185(14):2478-2494.e28. PubMed ID: 35662413
[TBL] [Abstract][Full Text] [Related]
14. Central glucagon like peptide-1 delays solid gastric emptying via central CRF and peripheral sympathetic pathway in rats.
Nakade Y; Tsukamoto K; Pappas TN; Takahashi T
Brain Res; 2006 Sep; 1111(1):117-21. PubMed ID: 16884700
[TBL] [Abstract][Full Text] [Related]
15. Peripheral oxyntomodulin reduces food intake and body weight gain in rats.
Dakin CL; Small CJ; Batterham RL; Neary NM; Cohen MA; Patterson M; Ghatei MA; Bloom SR
Endocrinology; 2004 Jun; 145(6):2687-95. PubMed ID: 15001546
[TBL] [Abstract][Full Text] [Related]
16. Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses.
Little TJ; Pilichiewicz AN; Russo A; Phillips L; Jones KL; Nauck MA; Wishart J; Horowitz M; Feinle-Bisset C
J Clin Endocrinol Metab; 2006 May; 91(5):1916-23. PubMed ID: 16492694
[TBL] [Abstract][Full Text] [Related]
17. Mycoprotein reduces energy intake and postprandial insulin release without altering glucagon-like peptide-1 and peptide tyrosine-tyrosine concentrations in healthy overweight and obese adults: a randomised-controlled trial.
Bottin JH; Swann JR; Cropp E; Chambers ES; Ford HE; Ghatei MA; Frost GS
Br J Nutr; 2016 Jul; 116(2):360-74. PubMed ID: 27198187
[TBL] [Abstract][Full Text] [Related]
18. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.
Näslund E; Barkeling B; King N; Gutniak M; Blundell JE; Holst JJ; Rössner S; Hellström PM
Int J Obes Relat Metab Disord; 1999 Mar; 23(3):304-11. PubMed ID: 10193877
[TBL] [Abstract][Full Text] [Related]
19. Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice.
Wismann P; Pedersen SL; Hansen G; Mannerstedt K; Pedersen PJ; Jeppesen PB; Vrang N; Fosgerau K; Jelsing J
Physiol Behav; 2018 Aug; 192():72-81. PubMed ID: 29540315
[TBL] [Abstract][Full Text] [Related]
20. Discovery of the GI Effects of GLP-1: An Historical Perspective.
Holst JJ
Dig Dis Sci; 2022 Jul; 67(7):2716-2720. PubMed ID: 35635627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
